Voima Ventures funds research-based deep technology. Pharmaceutical technology is interesting, drug development is not. Content (e.g. game) development is also not interesting, but related technology is.
They collaborate closely with universities and innovation service providers, for example universities’ internal innovation services.
They prefer to co-invest or lead. They seek a board seat when investing. In early stages they prefer to be actively involved in the management of the company.
Ticket size: €200k-€4,000k, sweet spot €750k, maximum allocation with follow-on investments €4,000k per company